GURUFOCUS.COM » STOCK LIST » Technology » Software » Cellebrite DI Ltd (NAS:CLBT) » Definitions » EBIT

Cellebrite DI (Cellebrite DI) EBIT : $-141.1 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cellebrite DI EBIT?

Cellebrite DI's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $9.2 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-141.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cellebrite DI's annualized ROC % for the quarter that ended in Mar. 2024 was 11.64%. Cellebrite DI's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 125.90%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cellebrite DI's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -7.00%.


Cellebrite DI EBIT Historical Data

The historical data trend for Cellebrite DI's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellebrite DI EBIT Chart

Cellebrite DI Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
1.55 11.40 82.46 120.91 -75.42

Cellebrite DI Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 -70.12 13.48 -93.66 9.25

Competitive Comparison of Cellebrite DI's EBIT

For the Software - Infrastructure subindustry, Cellebrite DI's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cellebrite DI's EV-to-EBIT Distribution in the Software Industry

For the Software industry and Technology sector, Cellebrite DI's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cellebrite DI's EV-to-EBIT falls into.



Cellebrite DI EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-141.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cellebrite DI  (NAS:CLBT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cellebrite DI's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=36.988 * ( 1 - -2.95% )/( (312.362 + 341.944)/ 2 )
=38.079146/327.153
=11.64 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=532.885 - 52.265 - ( 302.923 - max(0, 253.824 - 422.082+302.923))
=312.362

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=529.137 - 43.751 - ( 276.554 - max(0, 234.618 - 378.06+276.554))
=341.944

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Cellebrite DI's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=36.988/( ( (30.156 + max(-129.693, 0)) + (28.604 + max(-128.273, 0)) )/ 2 )
=36.988/( ( 30.156 + 28.604 )/ 2 )
=36.988/29.38
=125.90 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(77.269 + 9.94 + 31.95) - (52.265 + 196.587 + 2.8421709430404E-14)
=-129.693

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(61.643 + 9.259 + 30.604) - (43.751 + 186.028 + 0)
=-128.273

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cellebrite DI's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=-141.057/2015.192
=-7.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cellebrite DI EBIT Related Terms

Thank you for viewing the detailed overview of Cellebrite DI's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cellebrite DI (Cellebrite DI) Business Description

Traded in Other Exchanges
N/A
Address
94 Shlomo Shmelzer Road, P.O. Box 3925, Petah Tikva, ISR, 4970602
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.

Cellebrite DI (Cellebrite DI) Headlines

From GuruFocus

Cellebrite Announces Second-Quarter 2023 Results

By Marketwired 08-08-2023